Clinical experiences with a new semi-quantitative solid phase immunoassay for rapid measurement of procalcitonin

Clinical Chemistry and Laboratory Medicine

Volumn 38, Issue 10, 2000, Pages 989-995

  Meisner, M ^a   Brunkhorst, F M ^a   Reith, H B ^a   Schmidt, J ^a   Lestin, H G ^a   Reinhart, K ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Bedside diagnosis; Infection; Point of Care; Procalcitonin (PCT); Sepsis

Indexed keywords

PROCALCITONIN;

ANALYZER; ARTICLE; BLOOD ANALYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FOLLOW UP; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ASSAY; REFERENCE VALUE; SEPSIS; SEPTIC SHOCK; STATISTICAL ANALYSIS;

EID: 0033658657     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2000.147     Document Type: Article

References (30)

1. High serum procalcitonin concentrations in patients with sepsis and infection
2. Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: Comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia
3. Procalcitonin as a marker for the early diagnosis of neonatal infection
4. Procalcitonin in diagnosis of severe infections
5. Outcome predicition by traditional and new markers of inflammation in patients with sepsis
6. Sensitivity and specificity of various markers of inflammation for the prediction of tumor necrosis factor alpha and interleukin-6 in patients with sepsis
7. Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus/systemic antineutrophil cytoplasmatic antibody-associated vasculitis) and invasive bacterial infection
8. Procalcitonin in the early phase after renal transplantation - Will it add to diagnostic accuracy?
9. Early identification of biliary pancreatitis with procalcitonin
10. Procalcitonin: A new marker for differential diagnosis of acute rejection and bacterial infection in heart transplantation
11. Procalcitonin aids diagnosis of adrenocortical failure
12. Procalcitonin - Differentialdiagnose von Abstossungsreaktionen und nicht viralen Infektionen bei Transplantationspatienten
13. Differentialdiagnostik der Abstossungsreaktion und Infektion bei herztransplantierten Patienten: Neue Wege mit Zytokinen und Procalcitonin als Marker
14. Procalcitonin: A new marker for diagnosis of acute rejection and bacterial infection in patients after heart and lung transplantation
15. Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS
16. Procalcitonin as a marker of severity in septic shock
17. Procalcitonin serum concentrations and severity of sepsis
18. Procalcitonin in early detection of postoperative complications
19. Procalcitonin - Ein neuer Marker der inflammatorischen Wirtsantwort. Longitudinalstudien bei Patienten mit Sepsis und Peritonitis
20. Procalcitonin (PCT) - Ein neuer Parameter zur Diagnose und Verlaufskontrolle von bakteriellen Entzundungen und Sepsis
21. Procalcitonin: Erfahrungen mit einer neuen Messgroesse fuer bakterielle Infektionen und systemische Inflammation
22. Ein semi-quantitativer Schnelltest zur Bestimmung von Procalcitonin
23. Procalcitonin - Influence of temperature, storage, anticoagulation and arterial or venous asservation of blood samples on procalcitonin concentrations
24. Postoperative plasma concentrations of procalcitonin after different types of surgery
25. Postoperative plasma concentration of procalcitonin and C-reactive protein in patients undergoing cardiac and thoracic surgery with and without cardiopulmonary bypass
26. Procalcitonin (PCT) - Indications for a new diagnostic parameter of severe bacterial infection and sepsis in transplantation, immunosuppression and cardiac assist devices
27. Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock
28. Pyrexia, procalcitonin, immune activation and survival in cardiogenic shock: The potential importance of bacterial translocation
29. Procalcitonin in patients with sepsis and polytrauma
30. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis